4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001341896-26-000004
Director sold 221,951 shares at an average $33.51 ($7,438,111)
- Director acquired 196,601 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise | +31,668 | $4.99 | $158,023 | 131,400 | D |
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise | +71,492 | $7.94 | $567,646 | 202,892 | D |
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise | +77,181 | $8.43 | $650,636 | 280,073 | D |
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise | +16,260 | $14.70 | $239,022 | 296,333 | D |
| Fromkin Andrew J. Director | 2026-05-28 | Sale | −11,483 | $32.64 | $374,805 | 284,850 | D |
| Fromkin Andrew J. Director | 2026-05-28 | Sale | −210,468 | $33.56 | $7,063,306 | 74,382 | D |
| Derivatives | |||||||
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise · Stock Option (right to buy) | −31,668 | 0 | D | ||
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise · Stock Option (right to buy) | −71,492 | 0 | D | ||
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise · Stock Option (right to buy) | −77,181 | 0 | D | ||
| Fromkin Andrew J. Director | 2026-05-28 | Option exercise · Stock Option (right to buy) | −16,260 | 0 | D | ||
| Open-market sales · 221,951 sh · avg $33.51 · $7,438,111 | |||||||
Loading xslF345X06/wk-form4_1780085096.xml…